Tag: PALLAS study
-
Sanofi Heart Drug Multaq Found To Be Dangerous For Patients With Permanent Atrial Fibrillation
Analysis Of PALLAS Study Data Shows Two-Times Increased Risk Of Death, Stroke, And Heart Attack (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: FDA Drug Safety Communication: Review update of Multaq (dronedarone) and increased…
-
Multaq Cardiovascular Deaths Overshadow Earlier Liver Injury Concerns For Drug Regulators
FDA Now Looking At Two-Fold Increase In CV Deaths, Strokes, And Heart Failure Hospitalizations From PALLAS Study Data (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: "Multaq (dronedarone) – Information on Increase in Heart-Related…